Single small focus of prostate adenocarcinoma (≤ 1 mm and too small for grading) and clinical significant disease after radical prostatectomy

Archivio Italiano di Urologia e Andrologia

Volumn 78, Issue 2, 2006, Pages 57-60

  Taverna, Gianluigi ^a   Colombo, Piergiuseppe ^a   Seveso, Mauro ^a   Giusti, Guido ^a   Piccinelli, Alessandro ^a   Benetti, Alessio ^a   Graziotti, Pierpaolo ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Clinical significant disease; Gleason score; Prostatic biopsy; Small focus of prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; RADICAL RETROPUBIC PROSTATECTOMY; RETROSPECTIVE STUDY;

ADENOCARCINOMA; AGED; BIOPSY; DATA INTERPRETATION, STATISTICAL; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 33747252252     PISSN: 11243562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Humphrey P, Keetch D, Smith D, Shepard D, Catalona W. Prospective characterization of pathological features of prostatic carcinomas detected via serum specific antigen based screening. J Urol. 1996; 155:816
2. Okihara K, Fritcsche H, Ayala A, Johnston D, Allard WJ, Babaian R. Complexes prostate specific antigen and prostate volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng/ml. J Urol 2000; 165:1930
3. Roehl K, Antenor JA, Catalona WJ. Robustness of free prostate specific antigen measurements to reduce unnecessary biopsies in the 3.6 to 4.0 ng/ml range. J Urol 2002; 168:922
4. Presti JC, Chang JJ, Bhargava V, Shinoara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: result of a prospective clinical trial. J Urol 2000; 163:163.
5. Stewart C, Leibovich B, Weaver A, Lieber M. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001; 166:86
6. Hodge K, Mc Neal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142:71
7. Naya H, Ochiai A, Troncoso P, Babaian J. A comparison of extended biopsy and sextant biopsy schemes for predicting the pathological stage of prostate cancer. J Urol 2004; 171:6
8. Roehrborn CG, Pichens GJ, Sanders JS. Diagnostic yield of repeated transrectal ultrasound - guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels. Urology 1996; 47:347
9. Noguchi M, Yahara J, Koga H. Necessity of repeat biopsies in men for suspected prostate cancer. Int J Urol 1999; 6:7
10. Allen EA, Kahane H, Epstein J. Repeat biopsy strategy for men with atypical diagnoses on initial prostate needle biopsy Urology 1998; 52:803
11. Epstein J, Walsh P, Carmichael M, Brendler C. Pathologic and clinical findings to predict tumor extent of non palpable (stage T1C) prostate cancer. JAMA 1994; 271:368
12. Gardner, Lemer, Schiegel, Waldbaum, Darracott Vaughan Jr, et al. Microfocal prostate cancer: biopsy cancer volume does not predict actual tumor volume. Br J Urol 1998; 81:839
13. Stamey T, Freiha F, McNeal J, Redwine F, Witthemore A, Schmid HP. Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993; 71:933
14. Rubin M, Dunn R, Kambham N, Misick CP, O'Toole K. Should a Gleason Score be assigned to a minute focus of carcinoma on prostate biopsy? Am J Surg Pathol 2000; 24:1634
15. Allan R, Sanderson H, Epstein J. Correlation of minute (0.5 mm or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density. J Urol 2003; 170:370
16. Irwin M, Trapasso J. Identification of insignificant prostate cancer- Analysis of preoperative parameters. Urology 1994; 44:862
17. Cookson M, Fleshner N, Soloway S, Fair W. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol 1997; 157:563
18. Egevad L, Norberg M, Mattson S, Nolrle B, Busch C. Estimation of prostate cancer volume by multiple core biopsies before radical prostatectomy. Urology 1998; 52:653
19. Franks L. Latent carcinoma of prostate. J Path Bacteriol 1954; 68:603
20. Terris M, McNeal J, Stamey T. Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies. J Urol 1992; 148:829
21. Cupp M, Bostwich D, Mayers R, Oesterling J. The volume of prostate cancer in the individual basis. J Urol 1995; 153:1570